THE BRIEFING
BIONICAL SOLUTIONS / HEALTHCARE & TECHNOLOGY2026: HEALTHMANAGER INVESTMENTMED SELECT: FIVE PROGRAMS, ONE PLATFORM

COMPANY PROFILE / DIGITAL HEALTH

Bionical Solutions found a better way to engage: fewer platforms

Five education platforms became one, and more pharmaceutical reps used it. Inside the healthcare digital business that makes the next step easier for clinicians, patients and public-health teams.

Advertisement

The reps liked the software. They just weren’t using it enough. That awkward gap is the starting point for one of Bionical Solutions’ most useful stories: a pharmaceutical customer had accumulated separate education platforms, each serving its own brand priorities. A helpful collection had become a cumbersome routine. Bionical’s response was to bring the programs together.

It is a revealing introduction to a company whose work lives between a healthcare conversation and whatever happens next. Bionical designs digital tools and content for pharmaceutical businesses, the NHS and public-health services. Its territory includes the information a clinician shares, the referral an adviser processes and the reminder that brings a patient back. Much of the job is making these ordinary actions easier to complete.

Five doors into the same conversation

In its October 2025 account, Bionical described an unnamed pharmaceutical franchise that had developed five MED Select programs over five years. It consolidated them into one platform. Reps could personalise several unbranded educational resources without changing programs or logging additional Veeva calls. The company also reported simpler approvals, aggregated data and lower maintenance overhead.

“Although Reps provided positive feedback, overall utilization was lower than expected.”

Bionical Solutions · October 2025 case study

Comparing July through December 2024 with the same months in 2023, Bionical reported 94% more reps using the platform with healthcare professionals and 132% more customised educational materials created. Those are measures of adoption and output. They should be read as such, rather than as measurements of improved patient health.

MED Select / company-reported change
5→1
Separate programs → shared franchise platform
+94%Reps using the platform
+132%Customised materials created
Less switching, more use. July-December 2024 compared with July-December 2023; one unnamed customer.

The leaflet has a supply chain

MED Select lets pharmaceutical representatives and healthcare professionals assemble education suited to particular patients and counselling priorities. PM360’s 2020 profile described its integration with Veeva and the addition of remote and other engagement channels during the pandemic. The underlying task stayed recognisable: help a professional put relevant information in front of someone who needs it, even when the meeting cannot happen in person.

Bionical’s current engagement portfolio also includes MED Presenter and P2P Select. Across this portfolio, the company describes deployments in customer-management systems such as Veeva and OCE, web applications and iOS. It collects information about content use, preferences and engagement time. For a brand team, those records can inform what to revise; for the person receiving the material, relevance is the more immediate test.

The US operation shows how much labour sits behind that apparently simple exchange. Its listed disciplines include medical writing, health education, behavioural psychology, illustration, animation, programming and analytics. It also has production and fulfilment capabilities. A digital product here can involve deciding what to say, designing how to say it and arranging how the finished resource reaches its audience.

Its website displays client logos including Novo Nordisk, Biogen, Pfizer, AstraZeneca and Takeda. These are portfolio references, rather than a dated register of live contracts. The buying audience is clear, however: organisations that need healthcare communication produced and delivered within a demanding review process. Bionical sells the specialist work around the message as well as the software carrying it.

A stop-smoking service runs on details

On the public-health side, QuitManager handles the administrative life of a smoking-cessation service. Its G-Cloud listing describes referrals, appointments, text reminders, medication requests and reporting. It advertises more than 300 reports and more than 1,400 standard data fields per episode of care. That is a very different kind of product from a consumer app offering a daily motivational badge.

A Warwickshire guide for GP practices makes the workflow tangible. Staff create a client record, check a possible duplicate, open an episode and record a session. The guide also distinguishes an ordinary session from a four-week follow-up. These small procedural distinctions matter to the people doing the recording: the system must reflect the service they actually provide.

HealthManager extends the portfolio into areas including weight management and social prescribing, while the National Referral System supports connections between services. Bionical says its Healthware products serve hospital and community settings across the UK and Ireland. The common thread is continuity: helping services see where a person is in a pathway and what should happen next.

In an August 2026 article, digital business leader Becky Paul reported that services using QuitManager and HealthManager had managed more than one million patients. She described appointment tools, motivational messages and remote medication workflows as ways of reducing obstacles to participation. The scale is Bionical’s own reporting, and reflects services using its systems.

Official portrait of Becky Paul
Becky Paul leads the UK digital business. Her career has taken her through research, sales, training and operations.

“But information alone rarely changes behaviour.”

Becky Paul · August 2026

Her argument helps explain the connection between the company’s public-health and pharmaceutical work. Education needs somewhere to go. A message can explain the next step; the surrounding service must make that step possible. Bionical’s newer direction includes patient-facing portals, giving people more visibility into their progress while connecting back to professional workflows.

The bill has more than one line

QuitManager provides an unusually concrete view of Bionical’s commercial model. Its public price schedule, dated April 2024, separates the basic application from annual charges and optional work. That makes it possible to see how a configured healthcare product becomes an ongoing service relationship.

QuitManager / April 2024 schedule
Basic application£6,000
Community licence / year£7,500
Hosting / year£1,910

Separate published components. Excludes VAT, training, optional modules and other configuration costs.

The same schedule lists £5,250 for the specified migration package and £750 a day for bespoke development, consultancy or project management. Secondary-care licensing has a different annual price. The marketplace’s £14,500-per-instance headline is a separate listing figure; it should not be substituted for a scoped quotation assembled from the detailed schedule.

For a buyer, the useful habit is to cost the whole service: setup, recurring fees, migration, messaging and any extra modules. Bionical’s model combines software with delivery expertise. Its older group accounts describe software revenue alongside support, hosting and consumables, a reminder that the ongoing relationship can extend well beyond the initial build.

The custom work reveals the niche

Bionical’s bespoke portfolio gets more specific than the usual promise of digital transformation. HCP Connect lets professionals refer patients into nurse-led support programs and view progress through a central hub. A patient-consent platform offers educational emails after prescription, with content that can change according to the patient’s journey and recorded responses.

Another example is a familial mapping tool developed with a global pharmaceutical team and three affiliate markets, then rolled out in more than 35 countries, according to Bionical. An AI-enabled resource application answers healthcare professionals’ questions using the information held within its library. These are bounded tasks, with a defined audience and a particular information problem.

This places the business across several buying categories: healthcare communications, specialist software and public-health case management. A customer could assemble an agency, a development supplier and an internal team to cover comparable work. Bionical’s stated distinction is the combination of healthcare knowledge, research, design, development and quality assurance within one organisation.

It can also fit beside an existing agency. Its credentials describe arrangements in which the agency supplies copy, or copy and design, while Bionical builds the application. The approval responsibilities change with the arrangement. That flexibility matters commercially: a new tool does not necessarily require a pharmaceutical client to replace the people already responsible for its brand.

Older roots, a narrower focus

The company’s history needs more than a single birthday. The wider Bionical story dates to 2009, while the UK legal entity now called Bionical Solutions was incorporated in 2001. It later traded as North 51, a business that trade reporting dates to 2004. Bionical acquired North 51 in 2015, adding digital products, contract-sales and public-health capabilities.

In June 2024, Bionical announced that its clinical and commercial divisions would become separate legal and operating entities, with completion scheduled for August. The clinical operation became Bionical Health. The stated reason was greater autonomy to meet different growth requirements. Today’s Solutions website presents a specialist digital business, and its April 2026 retrospective describes clearer priorities after the separation.

Two people smiling in a photograph from Bionical’s company culture gallery
A change of screen. Bionical’s culture gallery includes this off-duty moment alongside its accounts of collaborative working.

The team’s published accounts favour autonomy, mutual help and attention to the end user. They are employer-selected perspectives, but the details add texture. CTO Andrew Seward previously worked at Experian and founded Tech Nottingham. Becky Paul’s background spans research, sales, training and operations. The work draws on people who have seen both the software and the conversation it is supposed to support.

Group selfie in an auditorium from Bionical’s culture gallery
Room for a few more. A group moment from Bionical’s culture gallery, with an audience stretching up the rows.

Make the next step worth taking

In February 2026, Bionical described further HealthManager investment, including more consistent implementation processes, a stronger knowledge base and staff development. The emphasis on getting services operational is revealing. A signed software contract is an intermediate event; the practical test arrives when someone has to use the system during a busy day.

For teams considering a similar approach, the design question is whether several tools genuinely serve the same task. Consolidation needs compatible content rules, clear ownership and a workable approval process. Where audiences or permissions must stay separate, fewer platforms may add complexity instead. The right unit of design is the job someone needs to finish.

Bionical’s story offers a useful discipline: examine what people do after saying they like a product. Then follow the work through the next handoff, the next appointment and the next piece of information. That is where an attractive digital idea earns its place in healthcare.